ENTITY
Amgen Inc

Amgen Inc (AMGN US)

165
Analysis
Health CareUnited States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
more
Refresh
01 Oct 2016 19:32

2016 US Elections Scenario Two: Donald Trump Wins

A US election fought under moderately favourable economic conditions, with a Republican electorate divided and openly unhappy with its...

Logo
210 Views
Share
01 Oct 2016 19:29

2016 US Elections Scenario One: Hillary Clinton Wins

A US election fought under moderately favourable economic conditions, with a Republican electorate divided and openly unhappy with its...

Logo
195 Views
Share
01 Oct 2016 19:07

On Trade, An Era Is Ending

Whatever the outcome of the US election, President Barack Obama's departure in early 2017 will present renewed challenges for Asia Pacific trade....

Logo
215 Views
Share
16 Sep 2016 07:57

Takeda Pharmaceutical - Is M&A the Way Out of Its Problems?

The FT has reported that Takeda Pharmaceutical may be back on the acquisition trail, with a US$15bil war-chest. This puts into the public domain a...

12 Sep 2016 22:34

US Stock Market Seasonality:  Shemitah Redux, The Afterparty

Almost exactly a year ago I wrote a piece on stock market seasonality titled Stock Market Seasonality - Januaries, SuperBowls, Third Years,...

Logo
222 Views
Share
x